Healthcare & Life Sciences
Nutcracker Therapeutics
United States
Nutcracker Therapeutics is a series b startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
1
Investors
About Nutcracker Therapeutics
Nutcracker Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Nutcracker Therapeutics is a biotechnology company focused on developing RNA therapeutics using a proprietary microfluidic biochip-based platform to enable rapid, scalable manufacturing of personalized treatments.
Explore Nutcracker Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.